Other languages Addex Therapeutics Ltd

Equities

Delayed Swiss Exchange Other stock markets 09:44:15 2024-05-07 am EDT			5-day change	1st Jan Change
0.072 ^CHF	-4.00%		+18.03%	+56.52%

Apr. 30	European Equities Traded in the US as American Depositary Receipts Decline	MT
Apr. 29	Sector Update: Health Care Stocks Edge Higher Late Afternoon	MT

European Equities Traded in the US as American Depositary Receipts Decline	Apr. 30
Sector Update: Health Care Stocks Edge Higher Late Afternoon	Apr. 29
Sector Update: Health Care	Apr. 29
Top Midday Decliners	Apr. 29
Addex Therapeutics Shares Plunge as Phase 2 Study of ADX71149 Falls Short of Primary Goal	Apr. 29
Tech Rally Subsides as US Equity Futures Waver Pre-Bell	Apr. 29
Top Premarket Decliners	Apr. 29
Addex Provides Update on ADX71149 Phase 2 Epilepsy Study	Apr. 29
Addex essuie un échec en étude clinique intermédiaire contre l'épilepsie	Apr. 29
Addex erleidet Forschungsrückschlag mit Epilepsie-Kandidaten	Apr. 29
Top Premarket Decliners	Apr. 24
Addex Therapeutics Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 18
Addex freine ses pertes et se concentre sur sa nouvelle organisation	Apr. 18
Addex dämmt Verluste ein - Fokus auf neue Struktur	Apr. 18
Addex Therapeutics Logs Decline in FY23 Net Loss; Revenue Rises	Apr. 18
Wall Street Set to Open Slightly Higher as Investors Await Wednesday's Inflation Data	Apr. 09
Top Premarket Gainers	Apr. 09
Powell Speech Eyed, Intel Weighs on Sentiment as US Equity Futures Waver Premarket	Apr. 03
Top Premarket Gainers	Apr. 03
Addex Therapeutics Announces the Launch of Neurosterix, Company Focused on Developing Allosteric Modulators for the Treatment of Underserved Neurological Disorders	Apr. 03

No results for this search